A carregar...
Lapatinib and erlotinib are potent reversal agents for MRP7(ABCC10)-mediated multidrug resistance
In recent years, a number of TKIs (tyrosine kinase inhibitors) targeting epidermal growth factor receptor (EGFR) family have been synthesized and some have been approved for clinical treatment of cancer by the FDA. We recently reported a new pharmacological action of the 4-anilinoquinazoline derived...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2953260/ https://ncbi.nlm.nih.gov/pubmed/19720054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2009.08.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|